Mood instability – A new outcome measure in randomised trials of bipolar disorder?

Research output: Contribution to journalComment/debateResearchpeer-review

Standard

Mood instability – A new outcome measure in randomised trials of bipolar disorder? / Kessing, Lars Vedel; Faurholt-Jepsen, Maria.

In: European Neuropsychopharmacology, Vol. 58, 2022, p. 39-41.

Research output: Contribution to journalComment/debateResearchpeer-review

Harvard

Kessing, LV & Faurholt-Jepsen, M 2022, 'Mood instability – A new outcome measure in randomised trials of bipolar disorder?', European Neuropsychopharmacology, vol. 58, pp. 39-41. https://doi.org/10.1016/j.euroneuro.2022.02.005

APA

Kessing, L. V., & Faurholt-Jepsen, M. (2022). Mood instability – A new outcome measure in randomised trials of bipolar disorder? European Neuropsychopharmacology, 58, 39-41. https://doi.org/10.1016/j.euroneuro.2022.02.005

Vancouver

Kessing LV, Faurholt-Jepsen M. Mood instability – A new outcome measure in randomised trials of bipolar disorder? European Neuropsychopharmacology. 2022;58:39-41. https://doi.org/10.1016/j.euroneuro.2022.02.005

Author

Kessing, Lars Vedel ; Faurholt-Jepsen, Maria. / Mood instability – A new outcome measure in randomised trials of bipolar disorder?. In: European Neuropsychopharmacology. 2022 ; Vol. 58. pp. 39-41.

Bibtex

@article{7057fabf4c1946d1a4d32ab1adf38d87,
title = "Mood instability – A new outcome measure in randomised trials of bipolar disorder?",
keywords = "Bipolar disorder, Digital monitoring, Mood instability",
author = "Kessing, {Lars Vedel} and Maria Faurholt-Jepsen",
year = "2022",
doi = "10.1016/j.euroneuro.2022.02.005",
language = "English",
volume = "58",
pages = "39--41",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Mood instability – A new outcome measure in randomised trials of bipolar disorder?

AU - Kessing, Lars Vedel

AU - Faurholt-Jepsen, Maria

PY - 2022

Y1 - 2022

KW - Bipolar disorder

KW - Digital monitoring

KW - Mood instability

U2 - 10.1016/j.euroneuro.2022.02.005

DO - 10.1016/j.euroneuro.2022.02.005

M3 - Comment/debate

C2 - 35219178

AN - SCOPUS:85125124404

VL - 58

SP - 39

EP - 41

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

ER -

ID: 299505381